A method is described for the simultaneous determination of urinary HMMA, 5-HIAA and HVA by HPLC with electrochemical detection. The method was evaluated over an 8-month period and has thus far identified 2 cases of phaeochromocytoma, 1 case of neuroblastoma and 2 of carcinoid tumour.
Detection rates for biogenic amine-secreting, neuroendocrine tumours are generally poor. Retrospective surveys reveal that more cases may be missed than are actually diagnosed during life. With phaeochromocytoma, more than 70'10 of cases may be discovered unexpectedly at surgery or during autopsy, I whereas with carcinoid tumours, about 90% have been found incidentally at autopsy.? Early diagnosis would allow an improved quality of survival for many years.>' The reasons for low detection rates are probably multifactorial and include a low index of suspicion by clinicians" and poor analytical performance of relevant biochemical tests by laboratories. ' There is some evidence that the use of a combination assay which simultaneously measures the metabolites of both pressor amines and serotonin may significantly improve tumour detection rates." In addition, assay of homovanillie acid (HVA) along with 4-hydroxy-3-methoxymandelic acid (HMMA) can be used as a prognostic indicator in malignant phaeochromocytoma; 7 is valuable in the identification of normotensive phaeochromocytoma.! and represents an appropriate combination for the detection of neuroblastoma." Also HV A in combination with 5-hydroxyindoleacetic acid (5-HIAA) may be useful in the evaluation of patients with suspected carcinoid tumours.'?
A need exists for a simple, reliable and accurate assay which simultaneously measures HMMA, 5-H lAA and HV A in urine. The technique of HPLC with electrochemical detection (HPLC-ECD) with its superior convenience, specificity and sensitivity over colorimetric techniques, makes it eminently suited to this analytical approach.
Experimental procedure REAGENTS AND EQUIPMENT HMMA, 5-HIAA, HVA, isovanillic acid (IsoVA) and other phenolic acids were obtained from Sigma Chemical Company, Poole, Dorset, UK. Methanol was supplied by Rathburn Chemicals Ltd, Walkerburn, Scotland, UK. All other chcmicals were purchased from BDH Chemicals Ltd, Poole, UK.
The HPLC system consisted ofa Waters Model 6000 A solvent delivery system and a U6K injector. The electrochemical detector was a TL-5 glassy carbon electrode obtained from Bioanalytical Systems Inc, West Lafayette, IN 47906, USA. Separation was achieved on a 150 x 4·6 mm ODS 5 11 particle size column (Bio Rad Laboratories Ltd, Watford, Herts, UK). The detector output was monitored on a Philips PM 8252 pen recorder.
HMMA was also assayed by the colorimetric method of Pisano et al," with modification, 12 120~-------------t he above findings, the following method protocol was adopted.
Method
(I) Stock combined standard contains 1·1 mmol each of HMMA, 5-HIAA and HVA per litre of 10 giL boric acid solution. Stored at 4"C, this solution is stable for at least 2 months.
(2) The stock internal standard solution consists of 100 mg IsoVA in 100 mL ethanol and is stable for at least 6 months. The working solution is prepared by diluting 0·2 mL to 10 mL with ethylacetate.
(3) Working phosphate buffer (pH 7'0) is prepared by mixing 41·3 mL of solution A (9'073g KH 2P04/L of water) and 58·7 mL of solution B (11'87g Na2HP04/L of water). (4) The mobile phase contains 10·9 g potassium dihydrogen orthophosphate and 100 mg ethylene-diamine tetra-acetic acid. These are dissolved in water and then 10 mL of 2 rnol/L orthophosphoric acid solution (Aristar grade) and 100 mL ofmethanol are added. The volume is made up to I L with water, mixed, filtered through a 0-45 p. filter and degassed before usc. +0·5 +0·6 +0·7 +0·8 +0·9
Applied voltage
FIG. I. Hydrodynamic voltammograms of the compounds of interest. A = 5-HIAA, B = HYA. c= HMMA, 0= lsoYA, E= atenolo\-associated peak, F=4-HPAA. SEPARATION An isocratic system avoids the need for expensive gradient elution apparatus and the attendant baseline drift due to varying mobile phase composition. Inclusion of the ion pairing reagent, tetrabutyl ammonium phosphate, was found not only to yield a poorer separation of 5-HIAA from interfering peaks but would also have tripled the cost of each batch of mobile phase. The mobile phase is therefore based on that described by Krstulovic.'? Relative retentions of HMMA, 5-HIAA, HVA and IsoVA can be finely adjusted by alteration of the pH and methanol concentration. Although it is possible to speed up the chromatography rate by increasing the solvent flow, there are two limitations to this, i.e. the resolution of the HMMA peak from the solvent front and, secondly, that of 5-HIAA from other potentially interfering peaks.
Specificity is further improved by employing a phosphate buffer back extraction at pH 7·0. The optimum time for the extractions to achieve equilibrium was found to be about 10 s in each case.
Urine specimens were best preserved with HC!. Acetic acid has been shown to be unsuitable as a urine preservation agent for 5-HIAA methods which employ a phosphate buffer back extraction step." For aqueous solutions, boric acid was shown to be a slightly better preservative for 5-HIAA, over a period of64 days, than HCI, H 2S04 or acetic acids, and hence the stock calibration standard is prepared in that agent.
Calibration was by the method of standard addition, in order to minimise matrix effects!' and to aid identification of interfering substances. Several compounds were investigated for their suitability as internal standard. Isovanillie acid (IsoVA) was selected because it is not present physiologically, pharmacologically or in the diet. IH Also it shows a retention time which is well separated from other peaks. It is stable, is extracted in the sample preparation procedure, reacts appropriately in the electrochemical detector and is both commercially available and relatively inexpensive. DETECTION Construction of hydrodynamic voltammograms revealed that an applied voltage of + 0·80 was the lowest which would allow detection of all four compounds with maximum sensitivity. However, a setting of +0·67 volts is employed in order to minimise drug interference ( where U and S are the analyte to internal standard peak height ratios of the unspiked and spiked samples respectively, and V is the 24 h urine volume in litres. Fig. 2 shows a typical chromatogram from a patient's urine with normal excretion by the above method. PRECISION Precision was assessed by replicate analysis of a commercial quality control urine preparation. Within-and between-batch coefficients of variation were 4·1 ' Yt, and 4·9'\{, for HMMA, 5·8% and 7· 1o/" for 5-HIAA, and 5·3% and 11·6% for HVA, at mean values of 79, 150 and 76 Jimol/L respectively. RECOVERY Relative recovery was determined by comparing the peak height increments achieved from spiked urines with that of an aqueous solution which contained the same amount of each analyte. If the peak height ratio achieved for the aqueous solution is Z, then for any given urine sample, relative percent recovery is given by the formula: S-(IO/ II x U) x 100/Z, where U and S have the same meanings as before.
Results
Recoveries were compared in 24 h urine preserved with either 10 g boric acid, 25 mL glacial acetic acid or 10 mL concentrated HC!. The results showed little difference between them. The mean relative recovery for the three analytes, from any of the preservative agents, was 97% with an average standard deviation (SD) of 5·7%. Recovery of 5-HIAA, from acetic acid-preserved urine, gave the lowest and most variable results with a mean of90'Yo and SD 9·5%. Hel was found to be a better preservative than boric acid for subsequent catecholamine analysis," and was therefore selected. Figs. 3 and 4 show the comparisons with a colorimetric method for HMMA and fluorescence polarisation for 5-HIAA respectively. Statistical analysis was performed by Deming's method using an in-house computer program." Although some difficulty was encountered in finding samples with high values, particularly for 5-HIAA, points did not deviate significantly from the line of equivalence. The comparisons with results from the United Kingdom external quality assessment scheme (UKEQAS) for urinary catecholamines are shown in Table I . They demonstrate average net deviations of +4,4% for HMMA and -1·1 %, for HVA, which indicates a satisfactory procedure. , , , Table 2 shows how the method performed when compared with the published mean target values for a commercial quality control urine preparation (Lyphochek II, Bio Rad Laboratories, Watford, Herts, UK). The figures quoted for the present method represent the between-batch mean of9 determinations and indicate acceptable performance.
COMPARISON OF RESULTS

REFERENCE RANGES
An assessment of an adult reference range was made by selecting specimens with results considered to be normal by our existing techniques for urinary HMMA and 5-HIAA. These consisted of 17 males and 21 females aged 21~80 years. Values were normally distributed and there was no significant difference between males and females. Mean results for excretion rates of HMMA, 5-HIAA and HVA were 20 (SO 6,2), 27 (SO 9'5) and 22 (SO 8,1) /lmol/24 h respectively, These results show good agreement with those determined by gas chromatography or HPLC-ECD techniq ues.21 24 The separation of 5-HIAA from other interfering compounds is the most difficult to achieve. Chromatograms from patients on atenolol showed a large peak at the retention time of 5-HIAA when detected at +0·80 volts. The peak was not atenolol itself since injection ofa solution of that substance produced no peak. A possible candidate for the interference is 4-hydroxyphenylacetic acid (4-HPAA). Retention times and hyd- rodynamic voltammograms, of 4-HPAA and the unknown peak, were identical. Atenolol ingestion results in urinary excretion of a substance which does give an apparently elevated 5-HIAA result in the nitrosonaphthol methods" and 4-HPAA gives a positive reaction." Although atenolol is largely excreted in the urine unchanged, 4-HPAA may represent a minor metabolite of the drug." The interference was eliminated by adopting an applied voltage of + 0·67 volts (Fig. I) .
Paracetamol did not interfere in the assay, but patients taking this drug showed a characteristic chromatogram with a peak which corresponded with paracetamol itself at about twice the retention time ofHMMA, and a further peak, presumably a metabolite, just after 5-HIAA.
Over the last nine months we have detected two cases of phaeochromocytoma, one case of neuroblastoma and two cases of carcinoid tumour with this method. The results are presented in Table 3 .
Discussion
The sample preparation step of the foregoing procedure, for an average batch size of 7 specimens, can be completed in about 20 min. The method represents a relatively quick, convenient and inexpensive technique for simultaneously handling the initial 'catecholamine' and 5-HIAA requests received in the hospital biochemistry laboratory. It demonstrates acceptable precision and accuracy together with a low sample volume req uiremen t.
Calibration by the method of standard addition was selected because previous experience has demonstrated two major advantages of this approach. First, matrix effects are not always predictable. Overcoming such effects may occupy much method development time, e.g. the effect of variable urine concentration on recovery between patients and aqueous standards." The second main advantage is in peak identification. Although this has not been a problem, so far, with the present technique, new drugs are being continuously added to the physician's armamentarium. There is always the possibility, with HPLC techniques, of misidentifying a drug or its metabolite for the peak of interest," The disadvantage of a resulting slower analysis rate can be circumvented by employing an automatic sampler and overnight running."
It is to be hoped that this technique, along with others published'v'" or yet to be reported, will contribute significantly to an improvement in neuroendocrine tumour detection rates. However, rates are more likely to improve with an increase in the total number of patients investigated. Additional identifiable groups to whom testing may be extended, using this method, could include all patients with (a) hypertension whose symptoms are unrelated to treatment;' (b) neurofibromatosis; (c) medullary carcinoma of the thyroid;" (d) or perhaps even hypercalciuria.v 31 The method has proved its clinical usefulness in validating the diagnosis in the cases already referred to in Table 3 . The inclusion of HV A in the profile shows a particularly interesting finding in a case of histologically confirmed carcinoid tumour. Urinary 5-HIAA was moderately elevated and HVA was greatly increased. Subsequent determination of dopamine" yielded a value of 14462 nmol/24 h. This commonly found pattern has been previously reported." and experience with the present method will enable some assessment of its clinical value.
